Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new method improves protein extraction from hair, helping identify potential biomarkers for fetal growth issues.

A new method helps find proteins in hair to identify fetal growth issues.

Hair cortisol levels may not reliably indicate psychological distress.

Peptides are being used to create biomaterials that can help diagnose and treat diseases.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Gelatin shows promise for future medical uses due to its safety and versatility, despite some challenges.

Nanozymes could improve cancer diagnosis and treatment by mimicking enzymes and enhancing delivery to tumors.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

SHBG may be a useful early indicator and treatment target for PCOS.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Erdr1 could be a new marker for diagnosing hair loss.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Small extracellular vesicles can help diagnose and manage sepsis.

Human hair protein modifications could potentially indicate heart disease risk.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

CEC levels may be a useful marker for predicting prostate cancer progression.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

8-OHdG may help diagnose and assess alopecia areata.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.